MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
IMTX — Immatics N.V. Ordinary Shares
NasdaqImmatics N.V. Ordinary Shares
$7.59
-0.85(-10.07%)
- O
- 8.56
- H
- 8.57
- L
- 7.40
- V
- 1.23M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About IMTX
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
IndustryCommon Stock
SectorNot available
IPO DateJul 2, 2020
Employees407
Stock ExchangeNasdaq
Ticker SymbolIMTX
Websitehttps://www.immatics.com
Key Financial Statistics
| Market Cap | $1.16B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $7.40 - $12.41 |
| 52-Week Avg Volume | 551.1K |
| VWAP | $7.69 |
| Transactions | 13,017 |
| Total Recorded Bars | 1,961 days |